CardiaMend and Amiodarone for the Prevention of POAF

Summary

The principal purpose of this investigator-initiated trial is to study the use of the CardiaMend device soaked in the anti-arrhythmic drug amiodarone, and how it may decrease the development of atrial fibrillation in patients that have undergone a coronary artery bypass surgery, or isolated valve surgery.

Timeline

Start

2023-01-01

Primary completion

2023-05-31

Completion

2023-05-31

Drugs

Indications